Browse
You are looking at 31 - 40 of 105 items for :
- Clinical Care x
- Refine by Content Type: News x
The American Society of Nephrology (ASN) commends the Centers for Medicare and Medicaid Services (CMS) and its Innovation Center (CMMI) for finalizing the End-Stage Renal Disease (ESRD) Treatment Choices (ETC) Model today. This model will herald positive changes to care for the more than 37 million Americans with kidney diseases, including more patient choice, increased utilization of home dialysis, and greater access to transplantation, options for which ASN has long advocated.
Consumer Reports (CR) recently published an article, “Medical Algorithms Have a Race Problem,” which recognized the potential impact ASN and the National Kidney Foundation (NKF) could have through their joint task force to reassess the inclusion of race in diagnosing kidney disease.
In August of 2020, the National Kidney Foundation (NKF) and the American Society of Nephrology (ASN) formed a joint task force to focus on the use of race to estimate GFR. For more information, please read the joint NKF-ASN statement on “Establishing a Task Force to Reassess the Inclusion of Race in Diagnosing Kidney Diseases.”
Ensure kidney patients get the vascular access surgeries they need, and don’t delay kidney transplant surgeries.
These two directives formed the centerpiece of recent guidance from the Centers for Medicare and Medicaid Services (CMS), “Key Components for Continued COVID-19 Management for Dialysis Facilities,” released Monday, August 17, 2020.
Terminology commonly used by physicians to describe kidney health may be distressing or too difficult to understand for patients with kidney diseases, according to a recent study published in CJASN. The study, “Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health,” included 54 patients with chronic kidney disease (CKD) and 13 caregivers from the United States, United Kingdom, and Australia. Participants discussed various terms for kidney health, including kidney, renal, CKD, end-stage kidney disease, kidney failure, and descriptors for kidney function.
Changes ASN has long pushed for will be implemented.
Nephrologists will receive a boost in payments – especially in the rate for reimbursement for home dialysis – made to them by the Centers for Medicare and Medicaid Services (CMS). ASN is proud to have played a significant role by pushing for this change that will begin January 1, 2021. This move is long overdue and reflects the priority placed on kidney care by the Executive Order on Advancing American Kidney Health of July 2019 and its focus on increasing rates of home dialysis.
The American Society of Nephrology’s (ASN) 21,000 members, who care for 37,000,000 Americans with kidney diseases, applaud the Trump Administration for issuing the Executive Order on Improving Rural Health and Telehealth Access on August 3, 2020. The Executive Order (EO) aims to increase access to better care for the approximately 57,000,000 Americans living in rural communities. The millions of Americans battling kidney diseases in rural communities are all too familiar with reduced access to quality care and insufficient bandwidth to support robust telehealth.
On July 2, the American Society of Nephrology (ASN) and the National Kidney Foundation (NKF) released a joint statement announcing the establishment of a joint task force that aims to reassess the includsion of race in diagnosing kidney diseases.
"Of the more than 37 million people affected by kidney diseases in the United States, a disproportionate number are of African American, Hispanic, Asian, and Native American descent. African Americans are three times more likely than Non-Hispanic Whites to experience kidney failure. Such disparities go beyond the high prevalence of kidney diseases and extend into differences in treatment modality, including access to transplantation. While African Americans represent 35% of people receiving dialysis in the United States, they are less likely to be identified as kidney transplant candidates when compared to Non-Hispanic White," begins the statment.
The American Society of Nephrology (ASN), the European Renal Association – European Dialysis and Transplant Association (ERA-EDTA), and the International Society of Nephrology (ISN) released a joint statement today. The statement emphasizes the need for appropriate care for dialysis patients during the COVID-19 pandemic.
“Preliminary data have shown that about 20-30% of patients hospitalized with COVID-19 develop kidney failure, leading to a surge in requirement for dialysis. Yet regular dialysis services have been interrupted to prepare hospitals to provide care to COVID-19 patients.”
